Cargando…

Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient

Objective(s):Arsenic compounds are potent human carcinogen and produce a variety of stress responses in mammalian cells. Recently sodium arsenite has been recommended to be used as anti malignancy drug by American food and drug administration (FDA). In this study, we aimed to determine the apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Abnosi, Mohammad Husein, Solemani Mehranjani, Malek, Momeni, Hamidreza, Shojafar, Elham, Barati, Mozhgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586908/
https://www.ncbi.nlm.nih.gov/pubmed/23493951
_version_ 1782261371371520000
author Abnosi, Mohammad Husein
Solemani Mehranjani, Malek
Momeni, Hamidreza
Shojafar, Elham
Barati, Mozhgan
author_facet Abnosi, Mohammad Husein
Solemani Mehranjani, Malek
Momeni, Hamidreza
Shojafar, Elham
Barati, Mozhgan
author_sort Abnosi, Mohammad Husein
collection PubMed
description Objective(s):Arsenic compounds are potent human carcinogen and produce a variety of stress responses in mammalian cells. Recently sodium arsenite has been recommended to be used as anti malignancy drug by American food and drug administration (FDA). In this study, we aimed to determine the apoptosis inducing effect of sodium arsenite on rat bone marrow mesenchymal stem cells exposed in vitro. Methodology:Cell morphology was studied with the help of Hoechst and propidium iodide as well as with single cell gel electrophoresis(comet assay), TUNEL assay and caspase activity base on immunocytochemistry using commercial kit were considered to study the mechanism of cell death. Results:Our result showed that the sodium arsenite with concentration of 0.1 µM in 36 hr induces caspase dependent apoptosis in rat bone marrow mesenchymal stem cells. This concentration is the lowest level of sodium arsenite to be reported with apoptosis induction ability in stem cells. Conclusion:Since sodium arsenite is used in therapy, more research should be carried out on the effect of this chemical on stem cells, especially MSCs.
format Online
Article
Text
id pubmed-3586908
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-35869082013-03-14 Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient Abnosi, Mohammad Husein Solemani Mehranjani, Malek Momeni, Hamidreza Shojafar, Elham Barati, Mozhgan Iran J Basic Med Sci Original Article Objective(s):Arsenic compounds are potent human carcinogen and produce a variety of stress responses in mammalian cells. Recently sodium arsenite has been recommended to be used as anti malignancy drug by American food and drug administration (FDA). In this study, we aimed to determine the apoptosis inducing effect of sodium arsenite on rat bone marrow mesenchymal stem cells exposed in vitro. Methodology:Cell morphology was studied with the help of Hoechst and propidium iodide as well as with single cell gel electrophoresis(comet assay), TUNEL assay and caspase activity base on immunocytochemistry using commercial kit were considered to study the mechanism of cell death. Results:Our result showed that the sodium arsenite with concentration of 0.1 µM in 36 hr induces caspase dependent apoptosis in rat bone marrow mesenchymal stem cells. This concentration is the lowest level of sodium arsenite to be reported with apoptosis induction ability in stem cells. Conclusion:Since sodium arsenite is used in therapy, more research should be carried out on the effect of this chemical on stem cells, especially MSCs. Mashhad University of Medical Sciences 2012 /pmc/articles/PMC3586908/ /pubmed/23493951 Text en © 2012: Iranian Journal of Basic Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Abnosi, Mohammad Husein
Solemani Mehranjani, Malek
Momeni, Hamidreza
Shojafar, Elham
Barati, Mozhgan
Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient
title Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient
title_full Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient
title_fullStr Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient
title_full_unstemmed Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient
title_short Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient
title_sort induction of apoptosis in the rat bone marrow mesenchymal stem cells following sodium arsenite treatment with the dose lesser than that used for treatment of malignant patient
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586908/
https://www.ncbi.nlm.nih.gov/pubmed/23493951
work_keys_str_mv AT abnosimohammadhusein inductionofapoptosisintheratbonemarrowmesenchymalstemcellsfollowingsodiumarsenitetreatmentwiththedoselesserthanthatusedfortreatmentofmalignantpatient
AT solemanimehranjanimalek inductionofapoptosisintheratbonemarrowmesenchymalstemcellsfollowingsodiumarsenitetreatmentwiththedoselesserthanthatusedfortreatmentofmalignantpatient
AT momenihamidreza inductionofapoptosisintheratbonemarrowmesenchymalstemcellsfollowingsodiumarsenitetreatmentwiththedoselesserthanthatusedfortreatmentofmalignantpatient
AT shojafarelham inductionofapoptosisintheratbonemarrowmesenchymalstemcellsfollowingsodiumarsenitetreatmentwiththedoselesserthanthatusedfortreatmentofmalignantpatient
AT baratimozhgan inductionofapoptosisintheratbonemarrowmesenchymalstemcellsfollowingsodiumarsenitetreatmentwiththedoselesserthanthatusedfortreatmentofmalignantpatient